AU2002239366A1 - Anti-angiogenic polypeptides - Google Patents
Anti-angiogenic polypeptidesInfo
- Publication number
- AU2002239366A1 AU2002239366A1 AU2002239366A AU3936602A AU2002239366A1 AU 2002239366 A1 AU2002239366 A1 AU 2002239366A1 AU 2002239366 A AU2002239366 A AU 2002239366A AU 3936602 A AU3936602 A AU 3936602A AU 2002239366 A1 AU2002239366 A1 AU 2002239366A1
- Authority
- AU
- Australia
- Prior art keywords
- seq
- plasminogen
- polypeptide
- human
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
- Enzymes And Modification Thereof (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25372500P | 2000-11-28 | 2000-11-28 | |
US60/253,725 | 2000-11-28 | ||
PCT/US2001/044515 WO2002044328A2 (en) | 2000-11-28 | 2001-11-28 | Anti-angiogenic polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002239366A1 true AU2002239366A1 (en) | 2002-06-11 |
Family
ID=22961462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002239366A Abandoned AU2002239366A1 (en) | 2000-11-28 | 2001-11-28 | Anti-angiogenic polypeptides |
Country Status (8)
Country | Link |
---|---|
US (2) | US7420036B2 (zh) |
EP (1) | EP1337548B1 (zh) |
CN (1) | CN100491394C (zh) |
AT (1) | ATE401337T1 (zh) |
AU (1) | AU2002239366A1 (zh) |
CA (1) | CA2426543C (zh) |
DE (1) | DE60134885D1 (zh) |
WO (1) | WO2002044328A2 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60134885D1 (de) | 2000-11-28 | 2008-08-28 | David M Waisman | Antiangiogene polypeptide |
AU2002357017A1 (en) | 2001-11-28 | 2003-06-10 | Mediomics, Llc | Anti-angiogenesis methods, compositions and uses therefor |
EP1501861A4 (en) * | 2002-05-06 | 2007-06-20 | Univ Texas | TARGETED BINDING PROTEINS FOR THE ADMINISTRATION OF THERAPEUTIC OR DIAGNOSTIC REAGENTS |
AU2003297181A1 (en) | 2002-12-13 | 2004-07-09 | Mediomics, Llc | Compositions and methods for inhibiting tumor growth and metastasis |
WO2006075165A1 (en) * | 2005-01-13 | 2006-07-20 | Btg International Limited | Combination of oncolytic viruses with angiogenesis inhibitors |
CN101219219B (zh) * | 2007-01-10 | 2013-02-13 | 北京普罗吉生物科技发展有限公司 | 包含血管抑素或其片段的复合物、其制备方法及应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1194135B (it) * | 1981-01-05 | 1988-09-14 | Novo Industri As | Composizioni di plasmina stabilizzata e metodo per la loro preparazione |
EP0467987A4 (en) | 1989-05-01 | 1992-07-08 | The University Of Notre Dame Du Lac | Methods and materials for expression of human plasminogen in a eukaryotic cell system |
US5837682A (en) | 1996-03-08 | 1998-11-17 | The Children's Medical Center Corporation | Angiostatin fragments and method of use |
US5639725A (en) | 1994-04-26 | 1997-06-17 | Children's Hospital Medical Center Corp. | Angiostatin protein |
US5945403A (en) | 1997-05-30 | 1999-08-31 | The Children's Medical Center Corporation | Angiostatin fragments and method of use |
IL126626A0 (en) | 1996-05-03 | 1999-08-17 | Abbott Lab | Novel antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis |
US5801012A (en) | 1996-09-17 | 1998-09-01 | Northwestern University | Methods and compositions for generating angiostatin |
WO1999000420A1 (en) | 1997-06-26 | 1999-01-07 | Karolinska Innovations Ab | Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
ID27676A (id) * | 1997-09-11 | 2001-04-19 | Sony Corp | Peralatan elektronik |
JP2001518304A (ja) | 1997-10-01 | 2001-10-16 | ジー・ディー・サール・アンド・カンパニー | アンギオスタチン成分を含む融合タンパク質及び抗腫瘍療法におけるその使用 |
ATE346607T1 (de) | 2000-09-01 | 2006-12-15 | Philadelphia Health & Educatio | Verfahren und zusammensetzungen zur inhibition der angiogenese |
DE60134885D1 (de) | 2000-11-28 | 2008-08-28 | David M Waisman | Antiangiogene polypeptide |
-
2001
- 2001-11-28 DE DE60134885T patent/DE60134885D1/de not_active Expired - Fee Related
- 2001-11-28 CA CA002426543A patent/CA2426543C/en not_active Expired - Fee Related
- 2001-11-28 WO PCT/US2001/044515 patent/WO2002044328A2/en not_active Application Discontinuation
- 2001-11-28 AU AU2002239366A patent/AU2002239366A1/en not_active Abandoned
- 2001-11-28 CN CNB01819642XA patent/CN100491394C/zh not_active Expired - Fee Related
- 2001-11-28 US US10/415,012 patent/US7420036B2/en not_active Expired - Fee Related
- 2001-11-28 AT AT01987119T patent/ATE401337T1/de not_active IP Right Cessation
- 2001-11-28 EP EP01987119A patent/EP1337548B1/en not_active Expired - Lifetime
-
2008
- 2008-07-31 US US12/183,896 patent/US7626008B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2002044328A3 (en) | 2003-04-03 |
US7420036B2 (en) | 2008-09-02 |
CA2426543A1 (en) | 2002-06-06 |
ATE401337T1 (de) | 2008-08-15 |
WO2002044328A2 (en) | 2002-06-06 |
EP1337548A2 (en) | 2003-08-27 |
US7626008B2 (en) | 2009-12-01 |
CN100491394C (zh) | 2009-05-27 |
US20090061510A1 (en) | 2009-03-05 |
EP1337548B1 (en) | 2008-07-16 |
US20040082030A1 (en) | 2004-04-29 |
CA2426543C (en) | 2007-09-18 |
DE60134885D1 (de) | 2008-08-28 |
EP1337548A4 (en) | 2005-01-12 |
CN1498223A (zh) | 2004-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2014210620B2 (en) | Antidotes for factor XA inhibitors and methods of using the same | |
ES2605801T3 (es) | Formulación de dosis unitaria de antídoto para inhibidores del factor Xa para su uso en la prevención de la hemorragia | |
ES2607935T3 (es) | Antídotos para inhibidores del factor Xa y procedimientos de uso de los mismos | |
JP5558106B2 (ja) | 凝固第vii因子関連ポリペプチドの皮下投与 | |
US7626008B2 (en) | Anti-angiogenic polypeptides | |
JP4986618B2 (ja) | 通常の細胞保護活性を有するが抗凝固活性が低下した活性化プロテインc変異体 | |
JP2010508031A (ja) | 通常の細胞保護活性を有するが抗凝固活性が低下した活性化プロテインc変異体 | |
US6833357B2 (en) | Compositions and methods for modulating muscle cell and tissue contractility | |
US6365364B1 (en) | Angiogenesis inhibitors and uses thereof | |
US20060099671A1 (en) | Methods and compositions for generating angiostatin | |
Kwon | Mechanism of Angiostatin Generation from Plasminogen |